Home News & Events New ICON survey highlights importance of combination therapies in future obesity treatment Read the press release ICON releases latest version of its Digital Platform Read the press release ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023 Read the press release Press releases 25 March 2024 ICON plc schedules first quarter 2024 earnings conference call 26 February 2024 ICON plc to Present at Upcoming Investor Conferences 21 February 2024 ICON Reports Fourth Quarter and Full Year 2023 Results 30 January 2024 ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call 24 January 2024 New ICON survey highlights importance of combination therapies in future obesity treatment 09 January 2024 ICON Issues Financial Guidance for Full Year 2024 08 January 2024 Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON 04 January 2024 ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference 18 December 2023 ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023 Events 27 March 2024 - 29 March 2024 ASCPT 10 April 2024 - 12 April 2024 Intellus Worldwide 15 April 2024 - 18 April 2024 AMCP 16 April 2024 - 18 April 2024 Innovation Summit 18 April 2024 - 19 April 2024 21st American Pharma and Biotech Project, Program and Portfolio Management Conference 23 April 2024 - 24 April 2024 Clinical Trials in Oncology WC 23 April 2024 Next Generation Sequencing Lunch and Learn 29 April 2024 - 1 May 2024 ISMPP Annual Meeting 2024 5 May 2024 - 8 May 2024 PMSA Awards ICON Press office enquiries Videos Media articles What’s happening in ICON